Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

NCT03517033 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Torrent's Nebivolol Tablets
DRUG: Forest Pharmaceuticals Inc.'s Bystolic Tablets

Sponsor

Torrent Pharmaceuticals Limited